News

These stocks were in great health last financial year. The post These 5 ASX 200 healthcare shares gained the most weight in ...
ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and ...
What trends should we look for it we want to identify stocks that can multiply in value over the long term? One ...
ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market.
ResMed (RMD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- ...
Shares of ResMed Inc. RMD rallied 1.11% to $258.00 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,204.95 and the ...
Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the appointment of Salli Schwartz as Chief ...
The stocks in this week’s article are Sprouts Farmers Market SFM, Adobe ADBE, GE Aerospace GE and ResMed RMD. Scoop Up These ...
Australia’s sharemarket is trading at a stretched valuation, so investors are vulnerable to firms where earnings momentum is ...